SpringWorks Therapeutics ...
(SWTX)
undefined
undefined%
At close: undefined
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -325.10M | -277.42M | -173.91M | -45.57M | -58.31M | -17.81M | -4.64M |
| Depreciation & Amortization | 1.67M | 765.00K | 490.00K | 349.00K | 192.00K | 17.00K | 3.18K |
| Stock-Based Compensation | 94.53M | 72.97M | 38.44M | 10.03M | 3.11M | 1.07M | - |
| Other Working Capital | 8.65M | 33.94M | 3.04M | 2.65M | 3.07M | 1.53M | 100.00K |
| Other Non-Cash Items | 6.69M | 4.02M | 993.00K | 1.05M | 2.61M | 612.33K | 1.74M |
| Deferred Income Tax | - | - | 988.00K | 605.00K | - | - | - |
| Change in Working Capital | -583.00K | 38.10M | 5.12M | 1.35M | 4.95M | 2.02M | 383.00K |
| Operating Cash Flow | -222.79M | -161.56M | -127.88M | -32.19M | -47.44M | -14.71M | -2.24M |
| Capital Expenditures | -7.38M | -10.20M | -2.02M | -642.00K | -670.00K | -293.00K | -44.00K |
| Acquisitions | -2.80M | -4.20M | 2.02M | -3.50M | -3.59M | - | - |
| Purchase of Investments | -575.72M | -481.05M | -305.42M | -442.69M | -3.59M | - | - |
| Sales Maturities Of Investments | 620.66M | 279.85M | 391.03M | 28.00M | 3.59M | - | - |
| Other Investing Acitivies | - | -205.40M | -2.02M | -418.19M | -3.59K | - | - |
| Investing Cash Flow | 34.75M | -215.60M | 83.59M | -418.83M | -4.26M | -293.00K | -44.00K |
| Debt Repayment | - | - | - | - | - | - | - |
| Common Stock Repurchased | -2.80M | -1.34M | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - |
| Other Financial Acitivies | 278.00K | 1.98M | 1.16M | 893.00K | 163.98M | 50.38M | 12.55M |
| Financial Cash Flow | 296.64M | 340.70M | 1.16M | 270.49M | 333.71M | 50.38M | 12.55M |
| Net Cash Flow | 108.60M | -36.46M | -43.13M | -180.54M | 282.00M | 35.38M | 10.27M |
| Free Cash Flow | -230.18M | -171.76M | -129.89M | -32.83M | -48.11M | -15.00M | -2.28M |